Removal of selected organic micropollutants from WWTP effluent with powdered activated carbon and retention by nanofiltration

Atmospheric and Biological Environmental Monitoring

Volumn , Issue , 2009, Pages 161-178

  Lehnberg, Kai ^a   Kovalova, Lubomira ^a   Kazner, Christian ^a   Wintgens, Thomas ^a   Schettgen, Thomas ^a   Melin, Thomas ^a   Hollender, Juliane ^a   Dott, Wolfgang ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Adsorption; Cytostatics; Endocrine disrupting compounds; Micropollutants; Nanofiltration; Powdered activated carbon; Water cycle

Indexed keywords

EID: 84882188293     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4020-9674-7_10     Document Type: Chapter

References (62)

1. Adler A, Steger-Hartmann T et al. (2001) Vorkommen natürlicher und synthetischer östrogener Steroide in Wässern des süd-und mitteldeutschen Raumes (Distribution of Natural and Synthetic Estrogenic Steroid Hormones in Water Samples from Southern and Middle Germany). Acta hydrochim hydrobiol 29(4):227-241.
2. Alaee M, Wenning RJ (2002) The significance of brominated flame retardants in the environment: current understanding, issues and challenges. Chemosphere 46:579-582.
3. Andersen H, Siegrist H et al. (2003) Fate of estrogens in a municipal sewage treatment plant. Environ Sci Technol 37(18):4021-4026.
4. Bellona C, Drewes JE et al. (2004) Factors affecting the rejection of organic solutes during NF/RO treatment - a literature review. Water Res 38(12):2795-2809.
5. Bilitewski D, Weltin P, Werner P (2002) Endokrin wirksame Substanzen in Abwasser und Klärschlamm - Neueste Ergebnisse aus Wissenschaft und Technik. Beiträge zur Abfallwirtschaft/Altlasten, Band 23 TU Dresden.
6. Brown KH, Schultz IR et al. (2007). Reduced embryonic survival in rainbow trout resulting from paternal exposure to the environmental estrogen 17α-ethynylestradiol during late sexual maturation. Reproduction 134(5):659-666.
7. Byrns G (2001) The fate of xenobiotic organic compounds in wastewater treatment plants. Water Res 35(10):2523-2533.
8. Cooke MD (1976) Antibiotic resistance in coliform and faecal coliform bacteria from natural waters and effluents. NZ J Mar. Freshwater Res 10(3):391-397.
9. Crittenden JC, Luft P, Hand DW (1985) Prediction of multicomponent adsorption equilibria in background mixtures of unknown composition. Water Res 19(12):1537-1548.
10. Danielsson LG, Zhang Y-H (1996) Methods for determining n-octanol-water partition constants Trends Anal Chem 15(4):188-196.
11. Ding L, Marinas BJ et al. (2006) Competitive effects of natural organic matter: parametrization and verification of the three-component adsorption model COMPSORB. Environ Sci Technol 40(1):350-356.
12. Dorne J, Skinner L et al. (2007) Human and environmental risk assessment of pharmaceuticals: differences, similarities, lessons from toxicology Anal Bioanal Chem 387(4):1259-1268.
13. Drewes, JE, Heberer T, Reddersen K (2002) Fate of pharmaceuticals during indirect potable use. Water Sci Tech 46(3):73-80.
14. Ebie K, Li F et al. (2001) Pore distribution effect of activated carbon in adsorbing organic micropollutants from natural water. Water Res 35(1):167-179.
15. Fent K (2003) Ecotoxicological problems associated with contaminated sites. Toxicol Lett 1 (13).
16. Fuerhacker M, Durauer A et al. (2001) Adsorption isotherms of 17[beta]-estradiol on granular activated carbon (GAC). Chemosphere 44(7):1573-1579.
17. Futselaar H, Schonewille H, van der Meer W (2002) Direct capillary nanofiltration - a new high-grade purification concept. Desalination 145:75-80.
18. Goi D, de Leitenburg C et al. (2004) Catalytic wet oxidation of a mixed liquid waste: Cod an aox abatement. Environ Tech 25(12):1397-1403.
19. Gore AC, Heindel JJ, et al. (2006) Endocrine disruption for endocrinologists (and Others). Endocrinology 147(6):1-3.
20. Graham MR, Summers RS et al. (2000) Modeling equilibrium adsorption of 2-methylisoborneol and geosmin in natural waters. Water Res 34(8):2291-2300.
21. Hansch C, Leo A, Hoekman D (1995) Exploring OSAR - Hydrophobic, Electronic and Steric Constants. American Chemistry Society, Washington, D. C.
22. Heberer T, Reddersen K, Mechlinski A (2002) From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas. Water Sci Tech 46(3):81-88.
23. Heberer T, Stan, HJ (1995) Polar environmental contaminants in the aquatic system. Occurrence and identification by GC-MS. GIT Fachz Lab 39(8):718.
24. Hegemann W, Busch K et al. (2002) Einfluss der Verfahrenstechnik auf die Eliminierung ausgewahlter Estrogene und Xenoestrogene in Klaranlagen-ein BMBF Verbundprojekt. Wasser - Abwasser 143:422-428.
25. Johnson AC, Jurgens MD et al. (2008) Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study J Hydrol 348 (1-2):167-175.
26. Kamiura T, Tajima Y, Nakahara T (1997) Determination of bisphenol A in air. J Environ Chem 7:275-279.
27. Kazner C, Fink G et al. (2007) Removal of organic micropollutants by nanofiltration in combination with adsorption on powdered activated carbon for artificial groundwater recharge with reclaimed wastewater. Proc 5th IWA Micropol & Ecohazard 2007 conference, Frankfurt/Main, 259-265.
28. Knappe DRU, Matsui Y et al. (1998) Predicting the capacity of powdered activated carbon for trace organic compounds in natural waters. Environ Sci Technol 32(11):1694-1698.
29. Koerner W, Bolz U et al. (2000) Input/output of estrogenic active compounds in a major municipal sewage plant in Germany. Chemosphere 40 (9-11):1131-1142.
30. Kolpin DW, Furlong ET et al. (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in U. S. Streams, 1999-2000: A national reconnaissance. Environ Sci Technol 36(6):1202-1211.
31. Kovalova L, McArdell CS et al. (2009) Challenge of high polarity and low concentrations in analysis of cytostatics and metabolites in wastewater by hydrophilic interaction chromatography/tandem mass spectrometry. Journal of Chromatography 1216(7):1100-1108.
32. Kümmerer K, Steger-Hartmann T et al. (1997) Biodegradability of the anti-tumour agent ifosfamide and its occurrence in hospital effluents and communal sewage. Water Res 31(11):2705-2710.
33. Mahnik SN, Lenz K et al. (2007) Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system. Chemosphere 66(1):30-37.
34. Matsui Y, Fukuda Y et al. (2003) Effect of natural organic matter on powdered activated carbon adsorption of trace contaminants: characteristics and mechanism of competitive adsorption. Water Res 37(18):4413-4424.
35. Meier J, Melin T (2005) Wastewater reclamation by the PAC-NF process. Desalination 178:27-40.
36. Meier J, Melin T, Eilers LH (2002) Nanofiltration and adsorption on powdered adsorbent as process combination for the treatment of severely contaminated waste water. Desalination 146:361-366.
37. Pandey S, Musarrat J (1993) Antibiotic resistant coliform bacteria in drinking water. J Environ Biol 14(4):267-274.
38. Petrovic M, Gonzales S, Barcelo D 2003 Analysis and removal of emerging contaminants in wastewater and drinking water. Trends Anal Chem 22(10):685-696.
39. Qi S, Schideman L et al. (2007) Simplification of the IAST for activated carbon adsorption of trace organic compounds from natural water. Water Res 41(2):440-448.
40. Scheytt T, Grams S et al. (2001) Pharmaceuticals in groundwater: clofibric acid beneath sewage farms south of Berlin, Germany. ACS Sympos Ser 791:84-99.
41. Schwarzenbach RP, Escher BI et al. (2006) The challenge of micropollutants in aquatic systems. Science 313(5790):1072-1077.
42. Sharpe RM, Skakkebaek NE (1993) Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract. The Lancet 341(8857):1392-1396.
43. Snyder SA, Adham S et al. (2007) Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 202 (1-3):156-181.
44. Snyder SA, Wert EC et al. (2006) Ozone oxidation of endocrine disruptors and pharmaceuticals in surface water and wastewater. Ozone Sci Eng 28(6):445-460.
45. Sontheimer H, Frick R et al. (1985) Adsorptionsverfahren in der Wasseraufbereitung, DVGW-Forschungsstelle am Engler-Bunte-Institut, Karlsruhe.
46. Spengler P, Körner W, Metzger JW (1999) Schwer abbaubare Substanzen mit östrogenartiger Wirkung im Abwasser von kommunalen und industriellen Kläranlagenabläufen. (Hardly degradable substances with estrogenic activity in effluents of municipal and industrial sewage plants). Vom Wasser 93:141-157.
47. Steger-Hartmann T, Kümmerer K et al. (1996) Trace analysis of the antineoplastics ifosfamide and cyclophosphamide in sewage water by two-step solid phase extraction and gas chromatography and mass spectrometry. Journal of chromatography A 726 (1-2):179-184.
48. Steger-Hartmann T, Kümmerer K, et al. (1997) Biological degradation of cyclophosphamide and its occurrence in sewage water. Ecotox Environ Safety 36(2):174-179.
49. Stelzer W, Ziegert E, Schneider E (1985) The occurrence of antibiotic-resistant Klebsiellae in wastewater. Zentralbl Mikrobiol 140(4):283-291.
50. Ternes TA (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32:3245-3260.
51. Ternes TA (2007) The occurrence of micopollutants in the aquatic environment: a new challenge for water management. Water Sci Tech 55(12):327-332.
52. Ternes TA, Joss A (eds.) (2006) Human Pharmaceuticals, Hormones and Fragrances: The Challenge of Micropollutants in Urban Water Management. IWA Publishing, London.
53. Ternes TA, Stumpf M et al. (1999) Behavior and occurrence of estrogens in municipal sewage treatment plants I. Investigations in Germany, Canada and Brazil. Sci Total Environ 225 (1-2):81-90.
54. US EPA. (2008) Estimation Programs Interface SuiteTM for Microsoft® Windows, v3.20. United States Environmental Protection Agency, Washington, DC, USA. http://epa.gov/oppt/exposure/pubs/episuite.htm. Accessed 10 April 2008.
55. Vieno N, Harkki MH et al. (2007) Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant. Environ Sci Technol 41(14):5077-5084.
56. von Gunten U (2003) Ozonation of drinking water: Part II. Disinfection and by-product formation in presence of bromide, iodide or chlorine. Water Res 37(7):1469-1487.
57. Webb S, Ternes T et al. (2003) Indirect human exposure to pharmaceuticals via drinking water. Toxicol Lett 142(3):157-167.
58. Welshons WV, Nagel SC et al. (2006) Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147(6):56-69.
59. Welshons WV, Thayer KA, et al. (2003) Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect 111(8):994-1006.
60. Wenzel A, Küchler T et al. (1998) Konzentrationen östrogen wirkender Substanzen in Umweltmedien (Concentration of estrogenic active substances in the environment). Umweltforschungsplan des Bundesministers fur Umwelt Naturschutz und Reaktorsicherheit. Umweltchemikalien/Schadstoffwirkungen. IUCT, Schmallenberg.
61. Wiedemeier TH, Wilson JT et al. (1999) Technical protocol for implementing intrinsic remediation with long-term monitoring for natural attenuation of fuel contamination dissolved in groundwater. U. S. Air Force Center for Environmental Excellence, v. 1&2, A324248, A324247a, A324247b.
62. Wintgens T, Melin T et al. (2005) The role of membrane processes in municipal wastewater reclamation and reuse. Desalination 178 (1-3):1-11.